Clinical trial
Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA)…
NCT00465933 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00465933 |
|---|---|
| Title | Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) |
| Official title | Treatment of Acute Promyelocytic Leukemia: Remission Induction With ATRA + Idarubicin (AIDA) Risk Adapted Intensity of Consolidation and Addition of ATRA Maintenance With ATRA + Methotrexate + Mercaptopurine Salvage Therapy for Molecular and Haematological Relapses |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Promyelocytic Leukemia |
| Intervention type | Drug |
| Interventions | AIDA |
| Start date | Mar 1, 1999 |
| Primary completion | Aug 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | Mar 31, 2008 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: